AI and medical technology firm Echo IQ Limited (ASX: EIQ) has inked a commercial licensing agreement with respiratory health MedTech company Respiri Limited (ASX: RSH) to incorporate Echo IQ’s EchoSolv cardiovascular decision support into Respiri’s remote patient monitoring (RPM) user base. As per the agreement, Respiri will integrate EchoSolv cardiovascular solutions into its U.S. Remote
Read More
As more businesses around the world seek solutions to address unreliable staff and reduce excess payroll expenses, artificial intelligence company UNITH (ASX: UNT) is solving all of these problems for them, signing its most clients in a single quarter to its Digital Human platform. Driving increased commercial activity has been tech advancements made in the
Read More
Covid made many things worse, including the lives of asthma patients who were more vulnerable to the disease than others. About 50 million Americans live with asthma, a respiratory disease involving inflammation in the airways, or COPD (chronic obstructive pulmonary disease). In the US, 30-day COPD re-admission rates are as high as 38%. In fact,
Read More
Marketing tech company Rewardle (ASX: RXH) is quickly building up a unique portfolio of small businesses where the company is backing themselves to lift their customers’ business so much that they have again secured equity options in lieu of their service fees. This time, it’s with medtech company Cardiac Rhythm Diagnostics. Both Rewardle and Cardiac
Read More
Medtech company Respiri (ASX: RSH) has continued its long path towards commercialisation of its asthma diagnostics device ‘wheezo’, having entered into a global manufacturing agreement with Entech Electronics for 12,000 devices. The agreement will see Entech manufacture the devices from their facilities in Shenzen, China. The order placed is for significantly more devices than the
Read More